Naji Mallat, MD
Biography
Expertise
- Benign Breast Diseases
- Hematology/Oncology
- Malignant Breast Diseases
Languages Spoken
Arabic, French, English
Office Locations
Patient Experience Reviews
4.8 out of 5
64 Ratings
Patient Comments (9)
Reviewed On 8/1/2023
Very good experience
Reviewed On 8/1/2023
The doctor was extremely kind and caring. Most importantly, knowledgeable about my condition
Reviewed On 6/1/2023
Dr Mallat Is very pleasant while remaining professional. He is definitely a valuable asset to UH.
Reviewed On 6/1/2023
Dr. Mallat and his team, ***, ***, ***, ***, and *** are all fantastic. ***
Reviewed On 6/1/2023
Dr Mallat is a new oncologist for me,vhe was excellent.
Reviewed On 5/1/2023
Very good experience
Reviewed On 4/1/2023
Dr. Mallat is a consummate professional who shows compassion and empathy for his patients. His medical knowledge and ability to explain things are two of his best qualities. I am grateful he is my oncologist.
Reviewed On 4/1/2023
Always very attentive - listens to my issues or concerns and provides wonderful feedback. Very comfortable with my doctor and staff. Thank you!
Reviewed On 4/1/2023
PA not the best.First time seeing Dr Mallat, pleased with him.
Certifications & Memberships
- Hematology - American Board of Internal Medicine
- Medical Oncology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Hematology/Oncology
Hematology/Oncology - UH Cleveland Medical Center (2019 - 2022)
Residency | Internal Medicine
Internal Medicine - UH Cleveland Medical Center (2017 - 2019)
Residency | Internal Medicine
Internal Medicine - American University Of Beirut Medical Center (2014 - 2017)
Other Education | Internal Medicine
Internal Medicine - American University Of Beirut (2017)
Medical Education
University Of Balamand Faculty Of Medicine And Medical Sciences (2011)
Undergraduate
American University Of Beirut (2007)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Naji Mallat did not disclose any Outside Relationships with Industry.